사람유두종바이러스의 검출과 유전자형 분석을 위한 HPV28 Detection 검사와 HPV DNA Chip 검사의 비교 평가
Comparative Evaluation of the HPV28 Detection and HPV DNA Chip Test for Detecting and Genotyping Human Papillomaviruses
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: The HPV28 Detection test (Seegene) is a real-time polymerase chain reaction assay that is designed for testing a total of 28 human papillomavirus (HPV) genotypes and estimating the approximate HPV viral load. The aim of this study was to evaluate the clinical applicability of the HPV28 Detection test with regard to the prevalence of HPV infection and distribution of HPV genotypes by using the HPV28 Detection and HPV DNA Chip tests (Biomedlab). Methods: HPV DNA Chip and HPV28 Detection tests were performed for 500 cervical swab specimens. HPV genotype results were confirmed by sequencing analysis of the specimens that showed discordant results in the 2 test methods. Results: The positive rate of HPV detection determined by using HPV28 Detection and HPV DNA Chip tests were 43.8% and 40.6%, respectively. The sequencing results in 64 discordant specimens that showed single HPV infection in the 2 test methods were in complete agreement with the test results obtained with the HPV28 Detection test. The genotyping results of the HPV28 Detection test were 100% concordant in repeated experiments with HPV-infected specimens that have 12 different HPV genotypes, i.e., types 16, 31, 33, 39, 42, 51, 52, 53, 58, 66, 68, and 70. The HPV28 Detection test was 100-fold more sensitive than the HPV DNA Chip test with serially diluted HPV DNAs. Conclusions: The HPV28 Detection test can be applied in the clinical field as an HPV genotyping test can accurately identify various HPV genotypes with high specificity and low detection limit.
Abstract
Background: The HPV28 Detection test (Seegene) is a real-time polymerase chain reaction assay that is designed for testing a total of 28 human papillomavirus (HPV) genotypes and estimating the approximate HPV viral load. The aim of this study was to evaluate the clinical applicability of the HPV28 Detection test with regard to the prevalence of HPV infection and distribution of HPV genotypes by using the HPV28 Detection and HPV DNA Chip tests (Biomedlab). Methods: HPV DNA Chip and HPV28 Detection tests were performed for 500 cervical swab specimens. HPV genotype results were confirmed by sequencing analysis of the specimens that showed discordant results in the 2 test methods. Results: The positive rate of HPV detection determined by using HPV28 Detection and HPV DNA Chip tests were 43.8% and 40.6%, respectively. The sequencing results in 64 discordant specimens that showed single HPV infection in the 2 test methods were in complete agreement with the test results obtained with the HPV28 Detection test. The genotyping results of the HPV28 Detection test were 100% concordant in repeated experiments with HPV-infected specimens that have 12 different HPV genotypes, i.e., types 16, 31, 33, 39, 42, 51, 52, 53, 58, 66, 68, and 70. The HPV28 Detection test was 100-fold more sensitive than the HPV DNA Chip test with serially diluted HPV DNAs. Conclusions: The HPV28 Detection test can be applied in the clinical field as an HPV genotyping test can accurately identify various HPV genotypes with high specificity and low detection limit.
참고문헌 (30)
- Bosch FX, "The causal relation between human papillomavirus and cervical cancer", J Clin Pathol, 55, pp.244~265 (2002)
- Sun CA, "Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions", Int J Gynaecol Obstet, 76, pp.41~47 (2002)
- Snijders PJ, "The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity", J Pathol, 201, pp.1~6 (2003)
- 김미경, "자궁경부암과 HPV 백신", 대한의사협회지, 52(12), pp.1180~1186 (2009), 대한의사협회
- Kim YT, "Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia", Int J Cancer, 126, pp.1903~1909 (2010)
- Lee MY, "Annual report of gynecologic cancer registry program in Korean for 2002 (Jan. 1st, 2002-Dec. 31st, 2002)", Korean J Obstet Gynecol, 47(S6), pp.1029~1070 (2004)
- Schiffman M, "ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants", Acta Cytol, 44, pp.726~742 (2000)
- Koss LG, "The Papanicolaou test for cervical cancer detection. A triumph and a tragedy", JAMA, 261, pp.737~743 (1989)
- Miller AB, "Report on consensus conference on cervical cancer screening and management", Int J Cancer, 86, pp.440~447 (2000)
- Monsonego J, "Cervical cancer control, priorities and new directions", Int J cancer, 108, pp.329~333 (2004)
- Nanda K, "Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities; a systematic review", Ann Intern Med, 132, pp.810~819 (2000)
- Fahey MT, "Meta-analysis of Pap test accuracy", Am J Epidemiol, 141, pp.680~686 (1995)
- Muñoz N, "Epidemiologic classification of human papillomavirus types associated with cervical cancer", N Engl J Med, 348, pp.518~527 (2003)
- Lee EH, "Clinical effectiveness of restriction fragment mass polymorphism assay for human papillomavirus genotyping", J Lab Med Qual Assur, 30, pp.291~299 (2008)
- Bosch FX, "Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group", J Natl Cancer Inst, 87, pp.796~802 (1995)
- Castellsagué X, "Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention", J Natl Cancer Inst, 98, pp.303~315 (2006)
- Clifford GM, "Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis", Br J Cancer, 88, pp.63~73 (2003)
- Hwang HS, "Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip", Cancer Epidemiol Biomarkers Prev, 13, pp.2153~2156 (2004)
- An HJ, "Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method", Cancer, 97, pp.1672~1680 (2003)
- Cho NH, "Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis", Am J Obstet Gynecol, 188(56), pp.56~62 (2003)
- 홍성란, "Prevalence and Genotype Distribution of Cervical Human Papillomavirus DNA in Korean Women: A Multicenter Study", Journal of Pathology and Translational Medicine, 43(4), pp.342~350 (2009), 대한병리학회
- Bae, Jeong-Hoon, "Human Papillomavirus (HPV) Type Distribution in Korean Women: A Meta-Analysis", Journal of Microbiology and Biotechnology, 18(4), pp.788~794 (2008), 한국미생물·생명공학회
- Shin HR, "Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea", J Infect Dis, 190, pp.468~476 (2004)
- Oh JK, "Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea", Eur J Cancer Prev, 18, pp.56~61 (2009)
- Kim YJ, "Prevalence of Human Papillomavirus Infection and Genotype Distribution Determined by the Cyclic-Catcher Melting Temperature Analysis in Korean medical checkup population", J Microbiol (2013)
- Fuessel Haws AL, "Nested PCR with the PGMY09", 11 and GP5(+), J Virol Methods, pp.2004, 122[DOI]
- Yitalo N, "Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study", Lancet, 355, pp.2174~2180 (2000)
- Elfgren K, "A population-based five-year follow-up study of cervical human papillomavirus infection", Am J Obstet Gynecol, 183, pp.561~567 (2000)
- 강지민, "HPV 백신 시대에 HPV DNA Chip 검사의 임상효용성- 1,211예 분석, 단일기관 보고 -", Annals of Laboratory Medicine, 28(1), pp.70~78 (2008), 대한진단검사의학회
- Chien-Fu Hung, "DNA vaccines for cervical cancer: from bench to bedside", Experimental and Molecular Medicine, 39(6), pp.679~689 (2007), 생화학분자생물학회